The Food and Drug Administration didn’t overstep its authority when denying Lotus Vaping Technologies LLC’s and Nude Nicotine Inc.'s requests for authorization to market flavored vaping products in the US, a federal appeals court ruled.
The agency concluded the benefits that their e-cigarette products offer to adults trying to quit smoking doesn’t outweigh the risks posed to youth, who could become addicted.
The US Court of Appeals for the Ninth Circuit rejected the companies’ arguments on July 7, agreeing with its sister circuits that the FDA didn’t introduce new evidentiary standards when considering the applications.
The petitioners argued the FDA ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.